DP
ELV icon

Dearborn Partners’s Elevance Health ELV Stock Holding History

Dearborn Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$354K Sell
1,208
-73
-6% -$24K 0.02% 210
2025
Q4 		$449K Hold
1,281
– – 0.02% 192
2025
Q3 		$414K Sell
1,281
-500
-28% -$156K 0.02% 192
2025
Q2 		$693K Buy
+1,781
New +$716K 0.03% 152
2024
Q4 		– Sell
-57,547
Closed -$29.9M – 265
2024
Q3 		$29.9M Sell
57,547
-1,652
-3% -$883K 1.21% 40
2024
Q2 		$32.1M Sell
59,199
-675
-1% -$357K 1.39% 33
2024
Q1 		$31M Sell
59,874
-20,498
-26% -$10.2M 1.33% 35
2023
Q4 		$37.9M Sell
80,372
-1,359
-2% -$628K 1.38% 36
2023
Q3 		$35.6M Buy
+81,731
New +$37.1M 1.4% 36

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dearborn Partners's ELV Position: Q1 2026 in Review

Dearborn Partners reduced its Elevance Health (ELV) stake by 5.7% in Q1 2026, selling an estimated $24K and leaving 1,208 shares worth $354K. The position accounts for 0.02% of the portfolio, ranked #210.

Dearborn Partners first reported a position in ELV in Q3 2023 and has held it in 9 quarters since. The position peaked at $37.9M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Dearborn Partners held 1,208 shares of Elevance Health worth $354K as of Q1 2026.
  • Dearborn Partners sold 73 Elevance Health shares in Q1 2026, an estimated $24K.
  • Elevance Health made up 0.02% of Dearborn Partners's portfolio in Q1 2026, its #210 holding.
  • Dearborn Partners first reported a position in Elevance Health in Q3 2023 and has held it in 9 quarters since.
  • Dearborn Partners's Elevance Health position peaked at $37.9M in Q4 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.